Stimuli-Responsive Nano-Architecture Drug-Delivery Systems to Solid Tumor Micromilieu: Past, Present, and Future Perspectives

Abstract

The microenvironment characteristics of solid tumors, renowned as barriers that harshly impeded many drug-delivery approaches, were precisely studied, investigated, categorized, divided, and subdivided into a complex diverse of barriers. These categories were further studied with a particular perspective, which makes all barriers found in solid-tumor micromilieu turn into different types of stimuli, and were considered triggers that can increase and hasten drug-release targeting efficacy. This review gathers data concerning the nature of solid-tumor micromilieu. Past research focused on the treatment of such tumors, the recent efforts employed for engineering smart nanoarchitectures with the utilization of the specified stimuli categories, the possibility of combining more than one stimuli for much-greater targeting enhancement, examples of the approved nanoarchitectures that already translated clinically as well as the obstacles faced by the use of these nanostructures, and, finally, an overview of the possible future implementations of smart-chemical engineering for the design of more-efficient drug delivery and theranostic systems and for making nanosystems with a much-higher level of specificity and penetrability features.

Ditelluride-Bridged PEG-PCL Copolymer as Folic Acid-Targeted and Redox-Responsive Nanoparticles for Enhanced Cancer Therapy

“…The stimuli-responsive drug release systems, which would be degraded by responding with the exogenous physicochemical stimulus (pH, reducing agent, light, temperature, etc. ) in tumor microenvironment, garnered considerable attention during the last decade (El-Sawy et al, 2018;Jiménez-Balsa et al, 2018;Li et al, 2018;Qu et al, 2018). Among numerous design, disulfide linkages were widely utilized to fabricate responsive systems due to the dramatical difference of the reducing glutathione (GSH) concentration between extracellular and intracellular microenvironment (ca.…”

Dual Stimuli‐Responsive Controlled Release Nanocarrier for Multidrug Resistance Cancer Therapy

“…In recent years, nanocarriers have been intensively investigated for cancer therapeutics . To date, many mechanisms have been proposed to regulate the time, rate and location of the drugs .…”

Poly(cyclodextrin)‐Polydrug Nanocomplexes as Synthetic Oncolytic Virus for Locoregional Melanoma Chemoimmunotherapy

“…In the context of cancer chemotherapy DDSs typically focus on increasing drug cytotoxic effects against tumors and minimizing them against host cells. [ 18 ] The small, gaseous nitric oxide (NO) has attracted significant attention in anticancer chemotherapy owing to its chemosensitizing effects via inhibition of drug efflux mechanisms. [ 19–21 ] Interestingly, NO participates in various immunological regulatory functions, [ 22 ] such as protection of DCs from tumor‐induced apoptosis, [ 23 ] activation of T H 1 cells, [ 24–27 ] DC maturation, [ 28 ] enhancement of DC migration, [ 29 ] inhibition of T reg s, [ 27 ] and improvement of the survival and differentiation of CTLs.…”